Feed/Investors/Sectoral Asset Management

Sectoral Asset Management

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on 2 rounds in the feed, most often in Healthtech.

Rounds from 2019-01-17 to 2026-09-16

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$159.5M

across 2 rounds

LATEST ROUND

Series C · $123M · 2026-09-16

CO-INVESTORS

named beside it

Rounds

[ 2 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Sling Therapeutics A biopharmaceutical company advancing oral linsitinib for thyroid eye disease	Series C Verified against 1 of 20 sources	$123M	2026-09-16	[ PART ]
HighLife HighLife develops a transcatheter system for replacing the mitral valve in patients with heart valve disease.	Series B Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$36.5M	2019-01-17	[ PART ]